These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32239739)

  • 1. New onset vitiligo in a patient with hidradenitis suppurativa treated with adalimumab.
    Phan K; Charlton O; Smith SD
    Dermatol Ther; 2020 May; 33(3):e13347. PubMed ID: 32239739
    [No Abstract]   [Full Text] [Related]  

  • 2. Case of bullous pemphigoid under treatment with adalimumab for hidradenitis suppurativa.
    Sugaya M; Ishii M; Takahashi-Shishido N; Ichimura Y; Morimura S
    J Dermatol; 2021 Apr; 48(4):e163-e164. PubMed ID: 33502014
    [No Abstract]   [Full Text] [Related]  

  • 3. Observational case series on adalimumab-induced paradoxical hidradenitis suppurativa.
    Delobeau M; Abdou A; Puzenat E; Deveza E; Biver-Dalle C; van de Laak A; Roche-Kubler B; Vuitton L; Koch S; Wendling D; Aubin F
    J Dermatolog Treat; 2016; 27(3):251-3. PubMed ID: 26368546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term adalimumab treatment of hidradenitis suppurativa: Results and practical insights from a real-life experience.
    Bettoli V; Manfredini M; Calamo G; Forconi R; Bencivelli D; Mantovani L; Pellacani G; Corazza M
    Dermatol Ther; 2018 Nov; 31(6):e12737. PubMed ID: 30295378
    [No Abstract]   [Full Text] [Related]  

  • 5. Adalimumab (Humira°) and hidradenitis suppurativa.
    Prescrire Int; 2017 Apr; 26(181):94-96. PubMed ID: 30730659
    [No Abstract]   [Full Text] [Related]  

  • 6. Tildrakizumab for the treatment of hidradenitis suppurativa in patients previously treated with adalimumab: a 30-month experience.
    Koszegi B; Wilson A; Stone C; Satgé F; Cowan TL; Murrell DF
    Clin Exp Dermatol; 2023 Oct; 48(11):1266-1269. PubMed ID: 37434310
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequential paradoxical psoriasiform reaction and sacroiliitis following adalimumab treatment of hidradenitis suppurativa, successfully treated with guselkumab.
    Garcia-Melendo C; Vilarrasa E; Cubiró X; Bittencourt F; Puig L
    Dermatol Ther; 2020 Nov; 33(6):e14180. PubMed ID: 32790040
    [No Abstract]   [Full Text] [Related]  

  • 8. Adalimumab-induced pyoderma gangrenosum in a patient with hidradenitis suppurativa: A paradoxical reaction.
    Company-Quiroga J; Alique-García S; Martínez-Morán C; Khedaoui R; Romero-Maté A; Borbujo J
    Indian J Dermatol Venereol Leprol; 2019; 85(4):422-425. PubMed ID: 31115357
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab.
    Harde V; Mrowietz U
    J Dtsch Dermatol Ges; 2009 Feb; 7(2):139-41. PubMed ID: 19371236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor necrosis factor (TNF)-induced lupus in a patient with hidradenitis suppurativa.
    Turk D; Vellaichamy G; Lyons AB; Parks-Miller A; Nelson T; Meysami A; Hamzavi IH
    Int J Dermatol; 2020 Mar; 59(3):e73-e74. PubMed ID: 31633193
    [No Abstract]   [Full Text] [Related]  

  • 11. Cellulitis-like Sweet Syndrome caused by adalimumab therapy for severe hidradenitis suppurativa.
    Canal Garcia E; Vargas Ramos JDP; Aguayo Ortiz R
    Australas J Dermatol; 2020 Nov; 61(4):e448-e449. PubMed ID: 32567672
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experience with adalimumab biosimilar imraldi in hidradenitis suppurativa.
    Ricceri F; Rosi E; Di Cesare A; Pescitelli L; Fastame MT; Prignano F
    Dermatol Ther; 2020 Nov; 33(6):e14387. PubMed ID: 33030281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical Reaction in a Patient with Hidradenitis Suppurativa Undergoing Adalimumab Treatment.
    Ikeya S; Takeichi T; Taki T; Muro Y; Ogi T; Akiyama M
    Acta Derm Venereol; 2021 Jun; 101(6):adv00484. PubMed ID: 34043022
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-dose adalimumab biosimilar (ZRC-3197) in the treatment of hidradenitis suppurativa.
    Patil S
    Indian J Dermatol Venereol Leprol; 2018; 84(6):745-747. PubMed ID: 30289113
    [No Abstract]   [Full Text] [Related]  

  • 15. Adalimumab-Induced Neutropenia in a Man With Hidradenitis Suppurativa.
    Rueda Carnero JM; Nieto Rodríguez D; de Lucas Laguna R; Feito Rodríguez M
    Actas Dermosifiliogr (Engl Ed); 2020 Apr; 111(3):273-274. PubMed ID: 31980127
    [No Abstract]   [Full Text] [Related]  

  • 16. Hidradenitis suppurativa in association with keratitis-ichthyosis-deafness syndrome treated with adalimumab.
    Song YM; Kim YS; Lee JH; Park YM; Lee JY
    J Dermatol; 2018 Sep; 45(9):e262-e263. PubMed ID: 29570225
    [No Abstract]   [Full Text] [Related]  

  • 17. Candida Esophagitis Associated With Adalimumab for Hidradenitis Suppurativa.
    Nazarian RS; Farberg AS; Smith BL
    Cutis; 2021 Mar; 107(3):E6-E7. PubMed ID: 33956612
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to 'Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis. Comment on "Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab"'.
    López Sanz P; Guzmán Pérez M; Guerrero Ramírez C; Manso Córdoba S; Alfaro Martínez ME; Azaña Defez JM
    Clin Exp Dermatol; 2023 Jul; 48(8):940-941. PubMed ID: 37098182
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term efficacy and safety of adalimumab on a severe case of hidradenitis suppurativa.
    Caposiena Caro RD; Cannizzaro MV; DI Raimondo C; DI Matteo E; Botti E; Rossi P; Bianchi L
    Ital J Dermatol Venerol; 2021 Feb; 156(1):101-102. PubMed ID: 30350561
    [No Abstract]   [Full Text] [Related]  

  • 20. Switching from adalimumab originator to biosimilars in hidradenitis suppurativa: What's beyond cost-effectiveness?
    Roccuzzo G; Rozzo G; Burzi L; Repetto F; Dapavo P; Ribero S; Quaglino P
    Dermatol Ther; 2022 Nov; 35(11):e15803. PubMed ID: 36062429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.